- SeeThruEquity,
LLC, in coverage update, projects that ETST will reach $7.1 million in
sales in FY2020 as it grows its product line and expands into full
spectrum cannabinoid beverages
- ETST’s
‘As Seen On TV’ campaign, with television celebrity Kevin Harrington as
spokesperson, is expected to help drive company sales in the CBD market to
$2.2 million by FY2019
- Leading
factors in forecast growth include company’s targeting of a fast-growing
sub-segment of the market in hemp-derived CBD, as well as the expanded
retail distribution of its product line, according SeeThruEquity research
Earth Science Tech, Inc. (OTCQB: ETST) is seen by research
firm SeeThruEquity as having diverse capabilities that will generate its growth
in the rapidly expanding CBD market, which is projected by Hemp Business
Journal to reach $2.1 billion by 2020 from $202 million in 2017, with $450
million of that increase coming from hemp-based sources, according to
Forbes (http://ibn.fm/y6OGz).
SeeThruEquity sees ETST’s participation in this booming
industry, focusing on the hemp-derived segment, as key to it reaching volume of
$7.1 million in sales by FY2020. The research report described its diversity,
including its line of nutraceuticals and pharmaceuticals, TV campaign and
uplisting to the OCTQB market, and calls Harrington a “potential catalyst” for
sales (http://ibn.fm/CU1uY).
“ETST appears positioned to compete for its share of this
market growth,” the report said, “as the company has established broad
distribution for its high purity CBD product line, covering more than 90,000
retail outlets. Moreover, the company’s pipeline remains robust with an
upcoming direct-to-consumer campaign with ‘As Seen On TV’ as well as planned
pharmaceutical products in coming years, funding permitting.”
ETST is a biotech company based in Doral, Florida, marketing
and developing CBD products, as well as dietary supplements for the
pharmaceutical and nutraceutical fields. The company is focused on the
cannabidiol, pharmaceutical and nutraceutical sectors, as well as the
development, through subsidiaries, of medical devices and research. ETST’s goal
is to become a world leader in the CBD space.
It is also moving ahead with the development of its Hygee
medical device, finalizing an agreement with Groupe Opmedic, Inc. and its
Procrea Fertility Laboratories for lab services to detect sexually transmitted
infections (STIs) in women using Hygee (http://ibn.fm/T8NDW).
In the CBD market, ETST is in discussions with an organic
grower and processor for an exclusive business/supply relationship that could
offer the company its outdoor organic industrial hemp plants, mixing,
extraction, bottling and packaging on an exclusive basis. The proposed deal
would give ETST a consistent industrial hemp source (http://ibn.fm/y6Am1).
ETST holds several wholly owned subsidiaries. Cannabis
Therapeutics is an emerging biotechnology company. KannaBidioiD manufactures
and distributes in the recreational sector. Earth Science Foundation, Inc. is
becoming a non-profit and accepts grants and donations to conduct additional
studies. Earth Science Pharmaceutical develops medical diagnostic tools and
vaccines. It also formed subsidiary Canno Inno Laboratories Inc., a strategic
Montreal, Canada-based company that provides ETST with access to government
grants.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
